The Icelandic founder mutation BRCA2 999del5: analysis of expression

INTRODUCTION: A founder mutation in the BRCA2 gene (BRCA2 999del5) accounts for 7–8% of female breast cancers and for 40% of male breast cancers in Iceland. If expressed, the mutant gene would encode a protein consisting of the first 256 amino acids of the BRCA2 protein. The purpose of this study wa...

Full description

Saved in:
Bibliographic Details
Published in:Breast Cancer Res
Main Authors: Mikaelsdottir, Evgenia K, Valgeirsdottir, Sigridur, Eyfjord, Jorunn E, Rafnar, Thorunn
Format: Artigo
Language:Inglês
Published: BMC 2004
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC468616/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15217494/
https://ncbi.nlm.nih.govhttps://doi.org/10.1186/bcr785
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items